October 25, 2022
1 min read
Save

Intra-articular injection in carpometacarpal joint for arthritis may provide pain relief

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Published results showed intra-articular injection provided significantly greater pain relief and functional improvement of thumb carpometacarpal joint arthritis at 3 months compared with extra-articular injection.

Perspective from Varun Gajendran, MD

“A steroid injection given into the [carpometacarpal] CMC joint of the thumb will provide, on average, longer lasting relief than when it is given outside of the joint,” Brian M. Katt, MD, told Healio.

Thumb OA
Source: Adobe Stock

Katt and colleagues used wrist radiographs to visualize location of the CMC joint injection with triamcinolone and radiopaque contrast among 102 hands with thumb CMC joint arthritis. Researchers collected DASH questionnaires and VAS pain scores before injection and at 1 week and 1, 3 and 6 months after injection. Researchers constructed generalized linear regression models to identify variables associated with clinical outcomes.

Brian M. Katt
Brian M. Katt

Results showed an intra-articular injection rate of 80%, with no differences found in pre-injection DASH or VAS scores between patients who received either an intra-articular injection or extra-articular injection.

Researchers found improvements in DASH and VAS scores after 1 week in both the intra-articular injection group and extra-articular injection group. Although both groups reported worse DASH and VAS scores at 3 months, researchers noted significantly lower DASH and VAS scores among patients in the intra-articular group. The intra-articular injection group and extra-articular injection group had no differences in DASH and VAS scores at 6 months, according to results. While significant improvements in outcomes were maintained in the intra-articular group for up to 6 months, researchers found improvements were only maintained in the extra-articular group for up to 1 month.

Researchers noted the Eaton-Littler classification was a predictor of DASH and VAS scores at 3 and 6 months.

“Providers should understand the implications of the study, which document the benefit of placing the steroid in a specific locale to maximize the change of short-term pain relief,” Katt said.